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TOPICS
•  Topic	1	–	General	Background	
•  Topic	2	–	Molecular	Basis		
•  Topic	3	–	Design	of	PET	Probe	
•  Topic	4	–	Preserva?on	of	Immunoreac?vity	
•  Topic	5	–	NU4PET	Preliminary	Injec?ons		
•  Topic	6	–	NU4	Histology	and	Morphology	
•  Topic	7	–	ACU193	Histology	and	Morphology	
•  Topic	8	–	ACU193PET	Preliminary	Injec?ons	
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Alzheimers	
Associa?on	2015	
MOLECULAR BASIS
•  Amyloid-β	plaques	
	
•  Neurofibrillary	tangles	
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Lieff	2015	
PBS	2016	
AMYLOID BETA PLAQUES
•  Amyloid	Precursor	Protein	(APP)	
•  Aβ42	vs	Aβ40	
•  Pep?de	à	oligomer	à	fibril	à	plaque	
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NIA	2016	
AMYLOID CASCADE HYPOTHESIS
•  Weak	correla?on	between	AD	and	
plaques	
•  Amyloid-β	oligomers	(AβOs)	
ini?ate	neurodegenera?on	
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NIA	2016	
BACKGROUND 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Medical	Care	
Corpora?on	
2015	
ANTIBODIES
	
•  Monoclonal	
•  NU4	-	mouse	
•  ACU193	-	human	
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Cell	Applica?ons	2015	
PET SYNTHESIS
•  PET	uses	radioac?ve	ligand	
•  Conjuga?on	of	DOTA	cage	to	
an?body	
•  Chela?on	with	radioac?ve	
compound/element	(64Cu)	
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AΒO ARE SEPARATE FROM PLAQUES
•  Demonstrate	that	AβOs	are	
separate	from	plaques	
•  Immunostained	tg	and	wt	mice	
with	568-NU4	(AβOs)	
•  Counterstained	with	ThioFlavin	
S	(amyloid	plaques)	
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Maira	Bicca	
DOTA BINDS TO THE FC REGION OF NU4
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NU4															NU4DOTA	
•  Electrophoresis"
•  Confirm DOTA binds to constant 
region"
•  NU4: 54.091 kDa"
•  NU4-DOTA: 56.849 kDa"
•  6-7 DOTA bound to heavy chain "
NU4DOTA RETAINS IMMUNOREACTIVITY TO ABOS
•  Dot	blots	
•  EC50			
	
•  No	decrease	in	
immunoreac?vity	
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NU4-DOTA COLOCALIZES WITH AΒOS	IN	VITRO 
	
•  NU4DOTA	and	FAM-AβOs	
in	primary	hippocampal	
neuron	culture		
•  High	levels	of	colocaliza?on	
•  Retained	immunoreac?vity	
in	vitro	
60
x	
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Maira	Bicca	
NU4PET DEMONSTRATE A STRONG AD DEPENDENT 
SIGNAL IN MICE
	
•  Tg	and	Wt	mice	injected	
•  NU4PET	
•  IgGPET	
•  NU4PET	demonstrates	a	strong	AD	
dependent	signal		
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Ting-Tung	Chang	
NU4PET DEMONSTRATES SUBSTANTIAL BRAIN UPTAKE
•  Blood	brain	barrier	is	
extremely	difficult	to	cross	
•  Percent	of	injected	dose	
retained	similar	to	PiB	and	
Florbetapir	
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Ting-Tung	Chang	
PET SIGNAL CORRELATES TO ACU193 
IMMUNOFLUORESCENT INTENSITY
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Condi8on	
Fluorescent	intensity	of	injected	brains	using	ACU193	
Wt	 Wt	 Wt	
•  Immunofluorescently	
labeled	brains	with	
ACU193	
	
•  Fluorescent	intensity	
correlates	to	PET	
signal	
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Tg	 Tg	 Tg	 Wt	 Wt	 Wt	Tg	 Tg	 Tg	
AΒOS ARE DETECTABLE AT 2 MONTHS IN 5XFAD MICE
•  Target	for	diagnosis	
must	appear	before	
onset	of	symptoms	
•  ERENNA	and	histology	
•  AβOs	are	detectable	at	2	
months		
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Erika	Cline	
NU4 DEMONSTRATES PLAQUE-LIKE AND PUNCTATE 
LABELING OF PYRAMIDAL LAYER IN 5XFAD MOUSE MODEL
•  Iden?fy	pathology	seen	in	our	5xFAD	
mouse	model	
	
•  Punctate	and	plaque-like	labeling	of	
the	dendri?c	arbors	
•  AβOs	found	primarily	in	
hippocampus,	dentate	gyrus	and	
along	the	pyramidal	layer	
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ACU193 DINSTINGUISHES BETWEEN DISEASED AND 
NONDISEASED HUMAN BRAINS
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ACU193 SHOWS PLAQUE-LIKE, PUNCTATE, AND 
DIFFUSE PATHOLOGY IN HUMAN BRAIN TISSUE
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ACU193DOTA DISTINGUISHES BETWEEN 5XFAD AND WT 
TISSUES DOWN TO 2 MONTHS (NU4 AND ACU193DOTA) 
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ACU193DOTA BINDS IN AN AGE DEPENDENT MANNER 
AND DISTINGUISHES BETWEEN TG AND WT MICE 
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Condi?on	
Integrated	Density	of	ACU193DOTA	Probe		
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ACU193PET SHOWS PROMISE IN DISTINGUISHING 
BETWEEN DISEASED AND NONDISEASED MICE
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DAY 1 RESULTS
Wild	Type	 5xFAD	
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DAY 1 RESULTS
Wild	Type	 5xFAD	
25 of 28         IMSAloquium 2017Topic	1	–	Topic	2	–	Topic	3	–	Topic	4	–	Topic	5	–	Topic	6	–	Topic	7	–	Topic	8	
CONCLUSION
•  ACU193PET demonstrates tremendous poten_al as an early diagnos_c imaging tool for AD
•  Future Work: 
•  Substan_a_ng AD specific probe signal by autoradiography using mouse and human brain sec_ons 
•  Dose curve PET to determine op_mal dosing range in mid-stage AD (5xFAD model)
•  Evalua_on of gross uptake and clearance in mice in vivo
•  Longitudinal analysis to determine earliest stages at which PET probe detects AβOs
•  Quan_ta_ve rela_onship between PET signals, AβOs detected histologically, AβOs detected 
biochemically, and memory loss
•  Human trial in 18 months
•  Dual MRI/PET
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